Evidence map›Paper›PMID 26488118›Full record

Trial reportJournal of pediatric gastroenterology and nutrition2015

Growth and Tolerance of Preterm Infants Fed a New Extensively Hydrolyzed Liquid Human Milk Fortifier.

Jae H Kim, Gary Chan, Richard Schanler, Sharon Groh-Wargo, Barry Bloom, Reed Dimmit, Larry Williams, Geraldine Baggs, Bridget Barrett-Reis

Erratum issued 2 registry-linked trialsOpen access · greenAbstract readComparative StudyMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Journal of pediatric gastroenterology and nutrition, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to 2 registered trials, which are not on this map. Cited by 25 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 5 pooled it
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03839173 naunknown statusnot on this mapstarted 2019, after this paper: background citation

Growth and Nutritional Status of Very Low Birth Weight Infants Fed a High Protein Exclusive Human Milk Diet

TypeinterventionalSponsorAugusta UniversityRan2019 to 2020Enrolled51ConditionsPremature Infant, Breast Milk ExpressionArmsHuman milk based human milk fortifier
NCT04478487 naunknown statusnot on this mapstarted 2019, after this paper: background citation

TITLE OF STUDY: Safety and Efficacy of a Novel Human Milk-based Human Milk Fortifier in Very Low Birth Weight Infants

TypeinterventionalSponsorNorthwest HealthRan2019 to 2024Enrolled40ConditionsInfant, Premature, DiseasesArmsMedolac human milk based human milk fortifier (MHMHMF)
3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 5 syntheses or guidelines pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Multi-nutrient fortification of human milk for preterm infants.The Cochrane database of systematic reviews · 2020
    Pooled it
  5. Milk feed osmolality and adverse events in newborn infants and animals: a systematic review.Archives of disease in childhood. Fetal and neonatal edition · 2019
    Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Article
  10. Review
  11. Article
  12. Observational
  13. Article
  14. Targeting optimal protein delivery in parenteral and enteral nutrition for preterm infants: a review of randomized, controlled trials.Journal of perinatology : official journal of the California Perinatal Association · 2024
    Review
  15. Human milk fortification and use of infant formulas to support growth in the neonatal intensive care unit.Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition · 2023
    Review
  16. Use of human milk and fortification in the NICU.Journal of perinatology : official journal of the California Perinatal Association · 2023
    Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

9 authors at 8 institutions in 1 country.

Jae H Kim*University of California, San Diego-Rady Children's Hospital of San Diego, San Diego †University of Utah, Salt Lake City ‡Cohen Children's Medical Center of New York, New Hyde Park §Case Western Reserve University, MetroHealth Medical Center, Cleveland, OH ||Wesley Medical Center, Wichita, KS ¶University of Alabama, Birmingham #Abbott Nutrition, Columbus, OH.
Gary Chan
Richard Schanler
Sharon Groh-Wargo
Barry Bloom
Reed Dimmit
Larry Williams
Geraldine Baggs
Bridget Barrett-Reis
Ross Laboratories (United States) · USAbbott Nutrition (United States)Cohen Children's Medical Center · USMetroHealth Medical Center · USRady Children's Hospital-San Diego · USUniversity of Alabama at Birmingham · USUniversity of Utah · USWesley Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThis study was a comparison of growth and tolerance in premature infants fed either standard powdered human milk fortifier (HMF) or a newly formulated concentrated liquid that contained extensively hydrolyzed protein.

methodsThis was an unblinded randomized controlled multicenter noninferiority study on preterm infants receiving human milk (HM) supplemented with 2 randomly assigned HMFs, either concentrated liquid HMF containing extensively hydrolyzed protein (LE-HMF) or a powdered intact protein HMF (PI-HMF) as the control. The study population consisted of preterm infants ≤33 weeks who were enterally fed HM. Infants were studied from the first day of HM fortification until day 29 or hospital discharge, whichever came first.

resultsA total of 147 preterm infants were enrolled. Noninferiority was observed in weight gain reported in the intent-to-treat (ITT) analysis was 18.2 and 17.5 g · kg(-1) · day(-1) for the LE-HMF and PI-HMF groups, respectively. In an a priori defined subgroup of strict protocol followers (n = 75), the infants fed LE-HMF achieved greater weight over time than those fed PI-HMF (P = 0.036). The LE-HMF group achieved greater linear growth over time compared to the PI-HMF (P = 0.029). The protein intake from fortified HM was significantly higher in the LE-HMF group compared with the PI-HMF group (3.9 vs 3.3 g · kg(-1) · day(-1), P < 0.0001). Both fortifiers were well tolerated with no significant differences in overall morbidity.

conclusionsBoth fortifiers showed excellent weight gain (grams per kilograms per day), tolerance, and low incidence of morbidity outcomes with the infants who were strict protocol followers fed LE-HMF having improved growth during the study. These data point to the safety and suitability of this new concentrated liquid HMF (LE-HMF) in preterm infants. Growth with this fortifier closely matches the recent recommendations for a weight gain of >18 g · kg(-1) · day(-1).

Indexed as

Enteral NutritionFood, FortifiedInfant, PrematureMilk, HumanWeight GainBody HeightDietary ProteinsDietary SupplementsEnergy IntakeFemaleGrowthHumansHydrolysisInfant FormulaInfant, NewbornMaleDietary Proteins

Identifiers

PMID26488118
PMCPMC4645956
OpenAlexW2175055898

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.